Agreed completely. I just figured it was also an easy reference point for people to have the figures in their mind so we can more readily tell what's what (despite the webinar doing that for us but still). But you're also right in the sense that this vaccine, while world class in results is actually just a test for a whole platform of new vaccine technology. To create a world class result on even the interim test results, while developing new tech is pretty unreal in itself. Best case the tech causes an exponential response overtime rather than linear or declining, because then we will sell the vaccine but also have the patent on technology that can do that. That is a genuine blue sky
AHZ Price at posting:
36.5¢ Sentiment: Buy Disclosure: Held
(20min delay)